Christopher Rossmann
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
Papers in
- Oncology 7
- Cancer Cells and Metastasis 3
- Pancreatic and Hepatic Oncology Research 2
- Inflammatory Biomarkers in Disease Prognosis 1
-
- Metastasis and carcinoma case studies 2
- Co-authors
- Jakob M. Riedl (7 shared papers)Armin Gerger (7 shared papers)Martin Pichler (7 shared papers)Michael Stotz (7 shared papers)Florian Posch (6 shared papers)Marija Balić (4 shared papers)Dominik A. Barth (2 shared papers)Herbert Stoeger (2 shared papers)
- Journals
- Anticancer Research (1 paper)Journal of Computer Assisted Tomography (1 paper)Oncotarget (1 paper)Scientific Reports (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- AustriaUnited StatesSwitzerland
In The Last Decade
Christopher Rossmann
11 papers receiving 229 citations
Peers
Comparison fields: 5 of 44
- Oncology 130
- Internal Medicine 12
- Cancer Research 37
- Pulmonary and Respiratory Medicine 48
- Immunology 32
Countries citing papers authored by Christopher Rossmann
This map shows the geographic impact of Christopher Rossmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Rossmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Rossmann more than expected).
Fields of papers citing papers by Christopher Rossmann
This network shows the impact of papers produced by Christopher Rossmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Rossmann. The network helps show where Christopher Rossmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Rossmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 81 | |
| 2 | 2021 | 39 | |
| 3 | 2017 | 24 | |
| 4 | 2021 | 23 | |
| 5 | 2019 | 17 | |
| 6 | 2020 | 14 | |
| 7 | 2017 | 11 | |
| 8 | 2017 | 10 | |
| 9 | 2017 | 9 | |
| 10 | 2019 | 2 | |
| 11 | 2017 | 1 |
About Christopher Rossmann
Christopher Rossmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Internal Medicine, having authored 11 papers that have together received 231 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Metastasis and carcinoma case studies (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (130 citations), Internal Medicine (12 citations), Cancer Research (37 citations), Pulmonary and Respiratory Medicine (48 citations) and Immunology (32 citations). Christopher Rossmann has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Jakob M. Riedl, Armin Gerger, Martin Pichler, Michael Stotz, Florian Posch, Marija Balić, Dominik A. Barth, Herbert Stoeger, Herbert Stöger and Angelika Terbuch. Their work appears in journals such as Anticancer Research, Journal of Computer Assisted Tomography, Oncotarget, Scientific Reports and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.